Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Collab Pharmaceutical Development is a professional Contract Research Organization (CRO) based in China, specializing in comprehensive clinical research services for the pharmaceutical and biotechnology sectors. Established in 2005, the company provides a full suite of services including drug registration, clinical trial design and management (Phases I-IV), bioequivalence (BE) studies, and medical writing. They are particularly recognized for their expertise in navigating the Chinese regulatory landscape and maintaining strong relationships with the National Medical Products Administration (NMPA). By bridging the gap between international drug development standards and domestic requirements, they assist both local and global clients in bringing therapeutic products to the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Collab Pharmaceutical Development.